Y
Yinuokang (Nanjing) Biopharmaceutical
At a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 11.0/100
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Dec 2023 | $14M | $55M | Ming Bioventures · Huajin Investment · Main Road Fund · China financial strategy | ↗ |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Yinuokang (Nanjing) Biopharmaceutical in the Nanjing City ecosystem
The Yinuokang (Nanjing) Biopharmaceutical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
Ming Bioventures- HIHuajin Investment
Main Road Fund- CSChina financial strategy
- HFHainan Longmen Fund
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Yinuokang (Nanjing) Biopharmaceutical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Yinuokang (Nanjing) Biopharmaceutical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.